Harris Poll tracks another pharma reputation drop with consumers, notes industry 'inflection point.'

Phar­ma rep­u­ta­tion falls again, notch­ing dou­ble-dig­it down­turn over past year in US — sur­vey

The phar­ma in­dus­try’s rep­u­ta­tion con­tin­ues to slip in the US as con­sumers pack away its pan­dem­ic hero sta­tus. The newest sur­vey from The Har­ris Poll shows the in­dus­try at a 45% pos­i­tive rat­ing last month, down 10 per­cent­age points from the same time last year.

While 45% is still above the just 32% pre-pan­dem­ic low that the in­dus­try held at be­gin­ning of 2020, it’s al­so no­tably low­er than the 62% high point in Feb­ru­ary 2021. The 10-per­cent­age point phar­ma drop since last fall is al­so the biggest de­crease across all the in­dus­tries that Har­ris Poll tracks, said man­ag­ing di­rec­tor Rob Jekielek.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.